Zhejiang Shengda Bio-Pharm Co., Ltd. Announcement on the Implementation of Annual Equity Distribution in 2023.
Legal opinion from Zhejiang Tiance Law Firm regarding differentiation dividend matters for Zhejiang Shengda Bio-pharmaceutical Co., Ltd. in 2023.
The issuer's financial report for the most recent year and its audit report and the most recent financial report
Zhejiang Shengda Biopharmaceutical Co., Ltd. Prospectus for Issuing Stock Securities to Specific Targets (Application Draft) (2023 Financial Data Update)
An indicative announcement by Zhejiang Shengda Biopharmaceutical Co., Ltd. on responding to the review inquiry letter and updating application documents such as prospectus for applying to issue shares to specific targets
CITIC Construction Investment Securities Co., Ltd. listing sponsorship for Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue shares to specific targets
Issuance letter from CITIC Construction Investment Securities Co., Ltd. regarding the issuance of shares by Zhejiang Shengda Biopharmaceutical Co., Ltd. to specific targets
Instructions from Tianjian Certified Public Accountants (Special General Partnership) on financial matters in the review inquiry letter of Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue shares to specific targets (revised draft) (2023 financial data update)
Response to the review inquiry letter on Zhejiang Shengda Biopharmaceutical Co., Ltd.'s application documents for issuing shares to specific targets (revised draft) (2023 financial data update)
Beijing Deheng Law Firm's Supplementary Legal Opinion on Zhejiang Shengda Biopharmaceutical Co., Ltd.'s issuance of A-shares to specific targets in 2023 (2)
Response to the second round review inquiry letter of Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue stock application documents to specific targets (revised draft) (2023 financial data update)
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
Legal Opinion of Zhejiang Tianze Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
Zhejiang Shengda Biopharmaceutical Co., Ltd. Stock Trading Risk Warning Notice
Response to the “Zhejiang Shengda Biopharmaceutical Co., Ltd. Stock Trading Abnormal Fluctuations Inquiry Letter”
Zhejiang Shengda Biopharmaceutical Co., Ltd. Stock Trading Abnormal Fluctuation Notice
Zhejiang Shengda Biopharmaceutical Co., Ltd. 2023 Annual General Meeting Meeting Meeting Materials
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the implementation results of share repurchase and share changes
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
No Data